All In Biotech

Free tool

FAERS Monitor: Zegerid Otc

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022281 or its brand name (Zegerid Otc, Omeprazole, Sodium Bicarbonate). Reports on generic versions are filed under their own applications.

Reports

339

Serious

294

87% of reports

Hospitalization

57

Death reported

29

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • chronic kidney disease224
  • acute kidney injury120
  • renal failure112
  • renal injury82
  • end stage renal disease65
  • tubulointerstitial nephritis38
  • gastrooesophageal reflux disease28
  • nephrogenic anaemia25
  • rebound acid hypersecretion25
  • nephropathy15
  • death13
  • renal impairment12
  • fatigue11
  • hyperparathyroidism secondary11
  • nausea11

Reports by year received

View as table
YearReports
20102
201111
20126
20135
20146
20152
20169
201714
201846
2019153
202028
202123
20229
20239
20247
20253
20266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,820 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rebound acid hypersecretionSignal25517.0353.912,265
nephrogenic anaemiaSignal25336.7230.67,993
hyperparathyroidism secondarySignal11273.7152.82,711
end stage renal diseaseSignal65221.9178.314,036
chronic kidney diseaseSignal224183.4169.940,491
renal injurySignal82171.7142.213,727
tubulointerstitial nephritisSignal38126.093.44,585
nephropathySignal1599.860.81,369
renal failureSignal11252.445.05,623
acute kidney injurySignal12048.742.25,594
gastrooesophageal reflux diseaseSignal2821.615.1531
renal impairmentSignal128.95.176
death130.90.50
fatigue110.90.50
nausea110.90.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.